Neurotensin receptor agonists and antagonists for schizophrenia.
Richelson
Elliott
E
Fredrickson
Paul A
PA
Boules
Mona M
MM
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001812:Blood-Brain Barrier / Q000187:drug effects; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D009496:Neurotensin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D018028:Receptors, Neurotensin / Q000819:agonists* / Q000037:antagonists & inhibitors; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D015507:Drugs, Investigational; D010446:Peptide Fragments; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; C407426:neurotensin 69L; C079087:SR 48692; D009496:Neurotensin